NO20003070L - Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav - Google Patents

Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav

Info

Publication number
NO20003070L
NO20003070L NO20003070A NO20003070A NO20003070L NO 20003070 L NO20003070 L NO 20003070L NO 20003070 A NO20003070 A NO 20003070A NO 20003070 A NO20003070 A NO 20003070A NO 20003070 L NO20003070 L NO 20003070L
Authority
NO
Norway
Prior art keywords
preparation
thiazolidine derivative
substituted thiazolidine
substituted
derivative
Prior art date
Application number
NO20003070A
Other languages
English (en)
Other versions
NO20003070D0 (no
NO317255B1 (no
Inventor
Ian Robert Lynch
Bernadette Marie Choudary
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20003070D0 publication Critical patent/NO20003070D0/no
Publication of NO20003070L publication Critical patent/NO20003070L/no
Publication of NO317255B1 publication Critical patent/NO317255B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20003070A 1997-12-16 2000-06-15 Substituert tiazolidinderivat, fremgangsmate for fremstilling og anvendelse derav NO317255B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726563.1A GB9726563D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical
PCT/EP1998/008153 WO1999031093A1 (en) 1997-12-16 1998-12-14 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use

Publications (3)

Publication Number Publication Date
NO20003070D0 NO20003070D0 (no) 2000-06-15
NO20003070L true NO20003070L (no) 2000-06-15
NO317255B1 NO317255B1 (no) 2004-09-27

Family

ID=10823691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003070A NO317255B1 (no) 1997-12-16 2000-06-15 Substituert tiazolidinderivat, fremgangsmate for fremstilling og anvendelse derav

Country Status (37)

Country Link
US (4) US20020133016A1 (no)
EP (1) EP1042321A1 (no)
JP (1) JP2002508371A (no)
KR (1) KR100549141B1 (no)
CN (3) CN101318957A (no)
AP (1) AP1363A (no)
AR (2) AR017211A1 (no)
AU (2) AU2272299A (no)
BG (1) BG64850B1 (no)
BR (1) BR9813598A (no)
CA (1) CA2314967A1 (no)
CO (1) CO4990943A1 (no)
CZ (1) CZ300081B6 (no)
DZ (1) DZ2679A1 (no)
EA (1) EA002833B1 (no)
EG (1) EG22250A (no)
GB (1) GB9726563D0 (no)
HR (1) HRP20000404A2 (no)
HU (1) HUP0102292A3 (no)
ID (1) ID24714A (no)
IL (2) IL136425A (no)
MA (1) MA26581A1 (no)
MY (1) MY128573A (no)
NO (1) NO317255B1 (no)
NZ (1) NZ504703A (no)
OA (1) OA11900A (no)
PE (1) PE20000125A1 (no)
PL (1) PL341213A1 (no)
RS (1) RS50080B (no)
SA (1) SA99200200B1 (no)
SK (1) SK286422B6 (no)
TR (2) TR200001793T2 (no)
TW (1) TW487709B (no)
UA (1) UA66821C2 (no)
UY (2) UY25309A1 (no)
WO (1) WO1999031093A1 (no)
ZA (1) ZA9811504B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CN1167702C (zh) * 1999-04-23 2004-09-22 史密丝克莱恩比彻姆有限公司 5-[4-[2-n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的多晶型物
EA003031B1 (ru) * 1999-04-23 2002-12-26 Смитклайн Бичам Плс Новый фармацевтический препарат
RS50114B (sr) 1999-04-23 2009-03-25 Smithkline Beecham P.L.C., Novi polimorfni oblik 5-/4-/2-(n-metil- n-(2-piridil)amino/ etoksi/benzil/ tiazolidin-2,4-dion, soli maleinske kiseline
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1732513A2 (en) * 2003-12-31 2006-12-20 Alpharma, Inc. Rosiglitazone formulations
EP1841414A1 (en) * 2003-12-31 2007-10-10 Alpharma, Inc. Rosiglitazone and metformin formulations
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
SG47100A1 (en) * 1994-02-10 1998-03-20 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
AU9123201A (en) 2000-09-26 2002-04-08 Reddy S Res Foundation Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation

Also Published As

Publication number Publication date
TR199802624A3 (tr) 1999-10-21
TR199802624A2 (xx) 1999-10-21
EA200000656A1 (ru) 2000-12-25
HRP20000404A2 (en) 2000-12-31
SK9182000A3 (en) 2000-12-11
PE20000125A1 (es) 2000-03-03
US7368574B2 (en) 2008-05-06
UY25306A1 (es) 2000-12-29
US20020133016A1 (en) 2002-09-19
KR100549141B1 (ko) 2006-02-03
TW487709B (en) 2002-05-21
NZ504703A (en) 2002-12-20
US20070037859A1 (en) 2007-02-15
PL341213A1 (en) 2001-03-26
MY128573A (en) 2007-02-28
AU2272299A (en) 1999-07-05
CO4990943A1 (es) 2000-12-26
EG22250A (en) 2002-11-30
AU770818B2 (en) 2004-03-04
HUP0102292A3 (en) 2003-12-29
KR20010033140A (ko) 2001-04-25
AP2000001829A0 (en) 2000-06-30
GB9726563D0 (en) 1998-02-11
EP1042321A1 (en) 2000-10-11
NO20003070D0 (no) 2000-06-15
CZ20002206A3 (cs) 2000-12-13
RS50080B (sr) 2009-01-22
TR200001793T2 (tr) 2000-10-23
SA99200200B1 (ar) 2006-11-11
AP1363A (en) 2005-01-21
BG64850B1 (bg) 2006-06-30
HUP0102292A2 (hu) 2002-05-29
JP2002508371A (ja) 2002-03-19
ZA9811504B (en) 2000-06-15
IL160847A0 (en) 2004-08-31
EA002833B1 (ru) 2002-10-31
UY25309A1 (es) 1999-07-19
CN1285831A (zh) 2001-02-28
UA66821C2 (uk) 2004-06-15
IL136425A0 (en) 2001-06-14
BR9813598A (pt) 2000-10-10
BG104606A (en) 2001-02-28
US20050288513A1 (en) 2005-12-29
DZ2679A1 (fr) 2003-03-29
IL136425A (en) 2004-08-31
MA26581A1 (fr) 2004-12-20
AR017211A1 (es) 2001-08-22
CN101318957A (zh) 2008-12-10
CN101318956A (zh) 2008-12-10
CZ300081B6 (cs) 2009-01-28
ID24714A (id) 2000-08-03
SK286422B6 (sk) 2008-09-05
YU36400A (sh) 2003-12-31
NO317255B1 (no) 2004-09-27
WO1999031093A1 (en) 1999-06-24
AU2753802A (en) 2002-05-16
OA11900A (en) 2006-04-10
US20030139604A1 (en) 2003-07-24
CA2314967A1 (en) 1999-06-24
AR016161A1 (es) 2001-06-20

Similar Documents

Publication Publication Date Title
NO20003070D0 (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO20000227L (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse
NO954239L (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO984150D0 (no) Elektrisk brönnloggefluid og fremgangsmåte for anvendelse derav
DK0729951T3 (da) Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder
NO980055D0 (no) Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav
EE04277B1 (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
NO993288D0 (no) Antimikrobiell handske og fremgangsmÕte for fremstilling derav
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20002181D0 (no) Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
EE04154B1 (et) Omeprasooli valmistamise meetod
NO991254L (no) FremgangsmÕter og mellomprodukter for fremstilling av substituerte kromanolderivater
NO985248L (no) Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilli
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
NO990913L (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
ID18300A (id) Metoda penemperan
NO20012099L (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser
NO962782L (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees